View Older Stories View More Recent Stories

Apr 7, 2026 02:40PM AstraZeneca (AZN) PT Raised to $220 at Morgan Stanley

Apr 7, 2026 02:38PM AstraZeneca (AZN:LN) (AZN) PT Raised to GBp16,500 at Morgan Stanley

Apr 7, 2026 02:09PM FDA approves multiple generics of Farxiga

Apr 2, 2026 07:00AM AstraZeneca's IMFINZI and IMJUDO combination shows progression benefit in liver cancer

Mar 31, 2026 01:55PM AstraZeneca (AZN) call put ratio 1.2 calls to 1 put as share price up 5%

Mar 31, 2026 01:50PM AstraZeneca (AZN) 6K contracts of April 220 calls trade

Mar 31, 2026 03:34AM AstraZeneca reports mixed results for HPP drug efzimfotase alfa

Mar 30, 2026 08:36AM TD Cowen Reiterates Buy Rating on AstraZeneca (AZN) Amid Potential 'Multi-Billion $ Opportunity'

Mar 27, 2026 04:33PM AstraZeneca (AZN) PT Raised to $220 at Leerink Partners

Mar 27, 2026 07:01AM AstraZeneca drug meets goals in two COPD trials

Mar 24, 2026 10:30AM Advancements in Novel Immunotherapeutics in The Oncology Battle

Mar 20, 2026 06:00AM These are the best EU pharma stocks to buy: analyst

Mar 18, 2026 09:26AM TD Cowen: 'AstraZeneca's (AZN) history of innovation offers opportunity for upside'

Mar 10, 2026 06:07AM AstraZeneca (AZN:LN) (AZN) PT Raised to GBP160 at Guggenheim

Mar 9, 2026 08:45AM ENHERTU receives priority review for HER2-positive early breast cancer

Mar 2, 2026 12:42PM AstraZeneca (AZN) PT Raised to $219 at Morgan Stanley

Mar 2, 2026 07:37AM AstraZeneca (AZN) PT Raised to $109 at Morgan Stanley

Feb 20, 2026 07:01AM AstraZeneca's CALQUENCE plus venetoclax wins FDA approval for CLL treatment

Feb 19, 2026 05:28AM EMA validates ENHERTU application for early breast cancer treatment

Feb 13, 2026 01:30PM This global pharma stock is ‘still underappreciated’, Bernstein says

Feb 13, 2026 07:02AM AstraZeneca BREZTRI shows lung function improvements in asthma trials

Feb 11, 2026 09:01AM AstraZeneca awards $3.4 million to nonprofits for health equity programs

Feb 10, 2026 07:05AM AstraZeneca (AZN) Reports Q4 EPS of $2.12; offers guidance

Feb 10, 2026 04:52AM AstraZeneca forecasts 2026 sales, profit growth as Q4 meets expectations; stock up

Feb 9, 2026 12:00PM AstraZeneca is set to report on Tuesday. Here's what to watch out for.

Feb 3, 2026 07:00AM FDA grants Priority Review to DATROWAY for metastatic triple-negative breast cancer

Feb 3, 2026 04:11AM FDA grants Priority Review to DATROWAY for metastatic breast cancer

Feb 2, 2026 07:01AM AstraZeneca starts trading on NYSE under harmonized global structure

Jan 30, 2026 07:11AM AstraZeneca partners with CSPC on weight management drugs for $1.2B

Jan 29, 2026 05:40AM AstraZeneca plans $15 billion China investment through 2030

Jan 27, 2026 10:52AM Citi initiates coverage of European pharma stocks; AstraZeneca 'best in class'

Jan 20, 2026 06:19AM AstraZeneca to move listing from NASDAQ to NYSE in January

Jan 14, 2026 01:11AM Guggenheim Reiterates Buy Rating on AstraZeneca (AZN:LN) (AZN)

Jan 13, 2026 02:50PM AstraZeneca acquires Modella AI to expand oncology AI capabilities

Jan 12, 2026 04:09AM Walmart to join Nasdaq-100 Index effective January 20

Jan 8, 2026 07:01AM AstraZeneca names Rick R. Suarez as US president and biopharmaceuticals head

Jan 6, 2026 04:36AM AstraZeneca's Saphnelo shows positive results in lupus trial

Jan 5, 2026 04:09AM BBVA USA (BBVA) and Haleon (HLN) Added to Goldman's European Conviction List Director's Cut for January 2026

Dec 22, 2025 07:01AM ENHERTU receives breakthrough designation for early breast cancer treatment

Dec 22, 2025 05:40AM AstraZeneca's (AZN) ENHERTU receives breakthrough therapy designation for early breast cancer

Dec 19, 2025 02:21PM Trump to announce prescription drug price agreements

Dec 19, 2025 08:51AM White House: Trump on Friday to announce more 'deals that will lower prices of drugs and pharmaceuticals'

Dec 18, 2025 04:41AM EMA validates application for DATROWAY as first-line treatment for TNBC

Dec 15, 2025 04:29PM ENHERTU plus pertuzumab wins FDA approval for HER2-positive breast cancer

Dec 15, 2025 02:30PM ENHERTU plus pertuzumab approved for first-line HER2+ metastatic breast cancer

Dec 9, 2025 09:58AM AstraZeneca (AZN) PT Raised to $105 at TD Cowen

Dec 9, 2025 09:28AM FDA launches fresh safety scrutiny of approved RSV therapies for infants - Reuters

Dec 4, 2025 04:00PM AstraZeneca selects Salesforce Agentforce for global customer engagement

Dec 4, 2025 07:02AM AstraZeneca presents largest-ever ASH presence with new blood cancer data

Dec 3, 2025 02:59AM AstraZeneca (AZN:LN) (AZN) PT Raised to GBP155 at Morgan Stanley

View More Recent Stories View Older Stories